This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Obsessive-compulsive disorder (OCD) is a mental condition defined by anxiety-inducing obsessive thoughts and beliefs, and the behaviors that are compulsively performed to ease the obsessions. Since this behavior ends up adding to the individual’s anxiety instead of soothing it, both the obsessive thoughts and compulsive actions that define OCD end up amplifying one another, necessitating treatment that can offer the individual suffering from OCD symptom relief. There are currently several established forms of treatment for OCD, with each offering its own level of efficacy and possible side effects. It is recommended you consult with your doctor to find the treatment best suited to your symptoms and needs.
Deep TMS: Deep Transcranial Magnetic Stimulation (dTMS) is a unique treatment course that uses magnetic fields to safely, effectively, and non-invasively reach brain structures associated with mental health conditions.
Deep TMS has been FDA-cleared to treat OCD since 2018, due to its ability to offer substantial relief to those battling this condition. This finding was confirmed by a 2019 multicenter, sham-controlled clinical study published in the American Journal of Psychiatry, which determined dTMS to effectively and safely alleviate symptoms of OCD, even among those patients who had not improved sufficient from medication or therapy.
As a non-invasive form of therapy, dTMS does not require anesthesia, can be incorporated into the individuals’ daily routine and does not cause any long-lasting or significant side effects.
Cognitive Behavioral Therapy: CBT is a form of talk therapy that is considered a first-line treatment for OCD. Under the guidance of a trained mental health professional, CBT focuses on the thoughts, feelings, behaviors and physical reactions involved in OCD. This is done in an effort to familiarize the patient with the condition’s different facets and gradually help alleviate its symptoms.
Over the years, several different types of therapy have branched out of CBT to offer patients with OCD greater symptom relief. Most notably among them is acceptance and commitment therapy (ACT): ACT promotes openness and flexibility when reacting to OCD symptoms, as the therapist helps the patient define and follow through with a commitment to their own well-being.
Exposure and response therapy (ERP) is an additional form of therapy found to effectively treat OCD. ERP helps the patient overcome their OCD by gradually exposing them to stimuli they associate with OCD-inducing anxiety. The patient is encouraged to refrain from reacting to the stimuli in a compulsory manner, and over time they become accustomed to managing OCD-related, anxiety-raising behavior.
Psychopharmacology: Medication is another form of therapy often considered a first-line treatment course for OCD. The FDA has approved several selective serotonin reuptake inhibitors (SSRIs), such as the branded medications Prozac and Zoloft, as well as one tricyclic antidepressant (TCA) to treat the condition, with SSRIs being the most commonly prescribed class of medication.
Though many patients battling OCD symptoms attest to the relief psychopharmacology has provided them, many also experience a number of side effects, and may decide to discontinue this form of treatment due to their severity.
Psychodynamic Therapy: Another form of therapy found to offer some relief to patients with OCD is psychodynamics. This treatment explores the relationships and events found, among other features of their life, to be fundamental to the patient’s sense of self, view of the world and personal narrative. These elements are then examined in relation to the adverse OCD symptoms they are experiencing, in an effort to understand the deeper reasons behind the ways they respond to the anxiety their condition produces within them. Over time, the patient is hopefully able to move away from automatically responding to their induced anxiety, as more flexible, pacifying and beneficial reactions take their place.
Despite the above-mentioned options available for those battling OCD, some patients do not experience relief from first-line or non-invasive treatments. As a result, treatment-resistant patients may be offered neurosurgical options by the healthcare professionals treating them.
Recent studies relying on different neurological lesion methods have shown some level of efficacy in alleviating OCD symptoms among treatment-resistant patients. These methods include gamma knife coagulative lesions, implanting radioactive seeds that cause local ablations, and standard craniotomy. Ablative, neurosurgical options always focus on the cortico-striato-thalamo-cortical circuit of the brain, which is believed to become hyperactive in patients facing OCD.
In addition to the invasiveness and necessary recovery period following such procedures, it should be stated that studies examining these techniques are normally based on open trials involving a limited number of patients. As a result, their efficacy among the general OCD population has yet to be established, and requires that larger, blinded studies determine how effective they are in alleviating OCD symptoms.